EGFR family: Structure physiology signalling and therapeutic targets †

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496 · see citing works

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,407 · see citing works

ERBB receptors and cancer: the complexity of targeted inhibitors

Hynes, N. E., & Lane, H. A. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1609 · Cited by 3,313 · see citing works

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

Ullrich, A., Coussens, L. M., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., et al. (1984) · Nature · doi:10.1038/309418a0 · Cited by 2,751 · see citing works

Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6

Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070 · see citing works

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Zhang, X., Gureasko, J., Shen, K., Cole, P. A., & Kuriyan, J. (2006) · Cell · doi:10.1016/j.cell.2006.05.013 · Cited by 1,650 · see citing works

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

Cho, H., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., & Leahy, D. J. (2003) · Nature · doi:10.1038/nature01392 · Cited by 1,615 · see citing works

Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor

Stamos, J. L., Sliwkowski, M. X., & Eigenbrot, C. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207135200 · Cited by 1,594 · see citing works

Epidermal growth factor receptor: Mechanisms of activation and signalling

Jorissen, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00098-8 · Cited by 1,565 · see citing works

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors

Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442 · see citing works

Requirement for neuregulin receptor erbB2 in neural and cardiac development

Lee, K., Simon, H. H., Chen, H., Bates, B., Hung, M., & Hauser, C. (1995) · Nature · doi:10.1038/378394a0 · Cited by 1,291 · see citing works

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized

van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,237 · see citing works

The discovery of receptor tyrosine kinases: targets for cancer therapy

Gschwind, A., Fischer, O. M., & Ullrich, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1360 · Cited by 1,227 · see citing works

Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains

Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227 · see citing works

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Guy, C. T., Webster, M. A., Schaller, M. D., Parsons, T. J., Cardiff, R. D., & Muller, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193 · see citing works

Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor

Gassmann, M., Casagranda, F., Orioli, D., Simon, H. H., Lai, C., Klein, R., & Lemke, G. (1995) · Nature · doi:10.1038/378390a0 · Cited by 1,151 · see citing works

Strain-Dependent Epithelial Defects in Mice Lacking the EGF Receptor

Sibilia, M., & Wagner, E. F. (1995) · Science · doi:10.1126/science.7618085 · Cited by 1,002 · see citing works

Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor

Schlessinger, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00966-2 · Cited by 995 · see citing works

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

Sergina, N. V., Rausch, M., Wang, D., Blair, J. A., Hann, B. C., Shokat, K. M., & Moasser, M. M. (2007) · Nature · doi:10.1038/nature05474 · Cited by 993 · see citing works

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

Şahin, U., Weskamp, G., Kelly, K., Zhou, H., Higashiyama, S., Peschon, J. J., Hartmann, D., Säftig, P., & Blobel, C. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307137 · Cited by 979 · see citing works

The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy

Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913 · see citing works

An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors

Burgess, A. W., Cho, H., Eigenbrot, C. W., Ferguson, K. M., Garrett, T., Leahy, D. J., Lemmon, M. A., Sliwkowski, M. X., Ward, C. W., & Yokoyama, S. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00350-2 · Cited by 908 · see citing works

γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase

Ni, C.-Y., Murphy, M. P., Golde, T. E., & Carpenter, G. F. (2001) · Science · doi:10.1126/science.1065412 · Cited by 858 · see citing works

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849 · see citing works

EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain Dimerization

Ferguson, K. M., Berger, M. B., Mendrola, J. M., Cho, H., Leahy, D. J., & Lemmon, M. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00047-9 · Cited by 801 · see citing works

Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor α

Garrett, T., McKern, N. M., Lou, M., ELLEMAN, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H., Walker, F., Frenkel, M. J., Hoyne, P. A., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00940-6 · Cited by 783 · see citing works

Phosphotyrosine interactome of the ErbB‐receptor kinase family

Schulze, W. X., Deng, L., & Mann, M. (2005) · Molecular Systems Biology · doi:10.1038/msb4100012 · Cited by 753 · see citing works

Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer

Baselga, J. M., & Arteaga, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.890 · Cited by 721 · see citing works

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.

Plowman, G. D., Culouscou, J., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., NEUBAUER, M., & SHOYAB, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1746 · Cited by 714 · see citing works

ErbB Receptors: Directing Key Signaling Networks Throughout Life

Holbro, T., & Hynes, N. E. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121440 · Cited by 642 · see citing works

Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor

Yarden, Y., & Schlessinger, J. (1987) · Biochemistry · doi:10.1021/bi00379a035 · Cited by 627 · see citing works

The Crystal Structure of a Truncated ErbB2 Ectodomain Reveals an Active Conformation, Poised to Interact with Other ErbB Receptors

Garrett, T., McKern, N. M., Lou, M., ELLEMAN, T. C., Adams, T. E., Lovrecz, G. O., Kofler, M., Jorissen, R. N., Nice, E. C., Burgess, A. W., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00048-0 · Cited by 614 · see citing works

Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation

Mann, G. B., Fowler, K. J., Gabriel, A., Nice, E. C., Williams, R. L., & Dunn, A. R. (1993) · Cell · doi:10.1016/0092-8674(93)90227-h · Cited by 583 · see citing works

Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development

Luetteke, N., Qiu, T. H., Fenton, S. E., Troyer, K. L., Riedel, R. F., Chang, A. Y., & Lee, D. C. (1999) · Development · doi:10.1242/dev.126.12.2739 · Cited by 568 · see citing works

Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins

Shuai, K., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Sadowski, H. B., Gilman, M. Z., & Darnell, J. E., Jr. (1993) · Nature · doi:10.1038/366580a0 · Cited by 509 · see citing works

Targeting Tyrosine Kinases in Cancer: The Second Wave

Baselga, J. M. (2006) · Science · doi:10.1126/science.1125951 · Cited by 478 · see citing works

ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice

Erickson, S. L., O’Shea, K. S., Ghaboosi, N., Loverro, L., Frantz, G. D., Bauer, M., Lu, L. H., & Moore, M. W. (1997) · Development · doi:10.1242/dev.124.24.4999 · Cited by 467 · see citing works

Structure of the Extracellular Region of HER3 Reveals an Interdomain Tether

Cho, H., & Leahy, D. J. (2002) · Science · doi:10.1126/science.1074611 · Cited by 447 · see citing works

Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation.

Gadella, T. W. J., & Jovin, T. M. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.129.6.1543 · Cited by 438 · see citing works

Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts

Carpenter, G., Lembach, K. J., Morrison, M., & Cohen, S. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41417-8 · Cited by 435 · see citing works

Aberrant Epidermal Growth Factor Receptor Signaling and Enhanced Sensitivity to EGFR Inhibitors in Lung Cancer

Amann, J. M., Kalyankrishna, S., Massion, P. P., Ohm, J. E., Girard, L., Shigematsu, H., Peyton, M., Juroske, D. M., Huang, Y., Salmon, J. S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.226.65.1 · Cited by 432 · see citing works

WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature

Lobov, I. B., Rao, S., Carroll, T. J., Vallance, J. E., Ito, M., Ondr, J. K., Kurup, S., Glass, D. A., Patel, M. S., Shu, W., et al. (2005) · Nature · doi:10.1038/nature03928 · Cited by 429 · see citing works

Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis

Silva, C. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208159 · Cited by 400 · see citing works

Cloning and sequence analysis of a cDNA for rat transforming growth factor-α

Lee, D. C., Rose, T. M., Webb, N. R., et al. (1985) · Nature · doi:10.1038/313489a0 · Cited by 387 · see citing works

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

Humphrey, P. A., Wong, A. J., Vogelstein, B., Zalutsky, M. R., Fuller, G. N., Archer, G. E., Friedman, H. S., Kwatra, M. M., Bigner, S. H., & Bigner, D. D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4207 · Cited by 382 · see citing works

Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts.

van Corven, E. J., Hordijk, P. L., Medema, R. H., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1257 · Cited by 378 · see citing works

Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer

Filardo, E. J. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00190-x · Cited by 374 · see citing works

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

Zhou, B.-B., Peyton, M., He, B., Liu, C., Girard, L., Caudler, E., Lo, Y. Y. C., Baribaud, F., Mikami, I., Reguart, N., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.024 · Cited by 370 · see citing works

Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.

Plowman, G. D., Whitney, G. S., NEUBAUER, M., Green, J. M., McDonald, V. L., Todaro, G. J., & SHOYAB, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.4905 · Cited by 366 · see citing works

Molecular Mechanisms of Epidermal Growth Factor Receptor (EGFR) Activation and Response to Gefitinib and Other EGFR-Targeting Drugs

Ono, M., & Kuwano, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0646 · Cited by 364 · see citing works

Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts.

Stoscheck, C. M., & Carpenter, G. (1984) · The Journal of Cell Biology · doi:10.1083/jcb.98.3.1048 · Cited by 358 · see citing works

Presenilin-Dependent ErbB4 Nuclear Signaling Regulates the Timing of Astrogenesis in the Developing Brain

Sardi, S. P., Murtie, J. C., Koirala, S., Patten, B. A., & Corfas, G. (2006) · Cell · doi:10.1016/j.cell.2006.07.037 · Cited by 349 · see citing works

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.

Stern, D. F., Heffernan, P. A., & Weinberg, R. A. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1729 · Cited by 331 · see citing works

A strain‐independent postnatal neurodegeneration in mice lacking the EGF receptor

Sibilia, M. C., Steinbach, J. P., Stingl, L., Aguzzi, A., & Wagner, E. F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.719 · Cited by 325 · see citing works

The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein–coupled receptors

Yan, Y., Shirakabe, K., & Werb, Z. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200112026 · Cited by 317 · see citing works

Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development

Ciarloni, L., Mallepell, S., & Brisken, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611647104 · Cited by 316 · see citing works

Cannabinoids Induce Cancer Cell Proliferation via Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM17)-Mediated Transactivation of the Epidermal Growth Factor Receptor

Hart, S., Fischer, O. M., & Ullrich, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3720 · Cited by 288 · see citing works

Signaling via ErbB2 and ErbB3 Associates with Resistance and Epidermal Growth Factor Receptor (EGFR) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells

Erjala, K., Sundvall, M., Junttila, T. T., Zhang, N., Savisalo, M., Mali, P., Kulmala, J. A. J., Pulkkinen, J. O., Grenman, R. A., & Elenius, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2404 · Cited by 257 · see citing works

Targeting TACE-dependent EGFR ligand shedding in breast cancer

Kenny, P. A., & Bissell, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29518 · Cited by 248 · see citing works

Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells

Wang, M. Y., Lu, K. V., Zhu, S., Dia, E. Q., Vivanco, I., Shackleford, G. M., Cavenee, W. K., Mellinghoff, I. K., Cloughesy, T. F., Sawyers, C. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4392 · Cited by 240 · see citing works

ErbB-4: mechanism of action and biology

Carpenter, G. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00100-3 · Cited by 232 · see citing works

Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.

Bargmann, C. I., & Weinberg, R. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5394 · Cited by 229 · see citing works

Tyrphostins and Other Tyrosine Kinase Inhibitors

Levitzki, A., & Mishani, E. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142657 · Cited by 225 · see citing works

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

Scott, A. M., Lee, F.-T., Tebbutt, N. C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611693104 · Cited by 223 · see citing works

Adjuvant Trastuzumab: A Milestone in the Treatment of HER-2-Positive Early Breast Cancer

Baselga, J. M., Perez, E. A., Pieńkowski, T., & Bell, R. H. (2006) · The Oncologist · doi:10.1634/theoncologist.11-90001-4 · Cited by 222 · see citing works

Essential Roles of Her2/erbB2 in Cardiac Development and Function

Negro, A. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.1 · Cited by 221 · see citing works

A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation.

Fowler, K. J., Walker, F., Alexander, W. S., Hibbs, M. L., Nice, E. C., Böhmer, R. ‐., Mann, G. B., Thumwood, C. M., Maglitto, R., & Danks, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1465 · Cited by 217 · see citing works

Epidermal Growth Factor Receptor–Mediated Signal Transduction in the Development and Therapy of Gliomas

Nicholas, M. K., Lukas, R. V., Jafri, N. F., Faoro, L. N., & Salgia, R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0874 · Cited by 215 · see citing works

Negative regulation of EGFR signalling through integrin-α1β1-mediated activation of protein tyrosine phosphatase TCPTP

Mattila, E., Pellinen, T. S., Nevo, J., Vuoriluoto, K., Arjonen, A., & Ivaska, J. (2004) · Nature Cell Biology · doi:10.1038/ncb1209 · Cited by 203 · see citing works

Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4

Golding, J. P., Trainor, P., Krumlauf, R., & Gassmann, M. (2000) · Nature Cell Biology · doi:10.1038/35000058 · Cited by 181 · see citing works

TNF-α induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-κB/p300 binding in human tracheal smooth muscle cells

Lee, C., Lin, C., Lin, W., Liang, K., Luo, S.-F., Wu, C.-B., Wang, S., & Yang, C. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00311.2006 · Cited by 173 · see citing works

Nuclear localization and possible functions of receptor tyrosine kinases

Carpenter, G. F. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00015-2 · Cited by 169 · see citing works

Distinct ADAM Metalloproteinases Regulate G Protein-coupled Receptor-induced Cell Proliferation and Survival

Schäfer, B., Marg, B., Gschwind, A., & Ullrich, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400129200 · Cited by 168 · see citing works

Role of Epidermal Growth Factor Receptor Pathway–Targeted Therapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Cohen, E. E. W. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4577 · Cited by 160 · see citing works

Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cells

Liu, B., Ordonez‐Ercan, D., Fan, Z., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22423 · Cited by 157 · see citing works

Epidermal growth factor receptor family (EGFR, ErbB2?4) in gliomas and meningiomas

Andersson, U., Guo, D., Malmer, B., et al. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0875-6 · Cited by 156 · see citing works

Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors

Sanderson, M. P., Dempsey, P. J., & Dunbar, A. J. (2006) · Growth Factors · doi:10.1080/08977190600634373 · Cited by 150 · see citing works

Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer

Tappenden, P., Jones, R. L., Paisley, S., & Carroll, C. (2007) · Health Technology Assessment · doi:10.3310/hta11120 · Cited by 150 · see citing works

Single‐molecule analysis of epidermal growth factor binding on the surface of living cells

Teramura, Y., Ichinose, J., Takagi, H., Nishida, K., Yanagida, T., & Sako, Y. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601308 · Cited by 148 · see citing works

Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis

Herbst, R. S., Heymach, J. V., O’Reilly, M. S., Onn, A., & Ryan, A. J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.2.239 · Cited by 144 · see citing works

ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II

Ohtsu, H., Dempsey, P. J., Frank, G. D., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000236203.90331.d0 · Cited by 140 · see citing works

Signaling through ERBB receptors: Multiple layers of diversity and control

Warren, C. M., & Landgraf, R. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.12.007 · Cited by 132 · see citing works

Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart

Sibilia, M. C., Wagner, B., Hoebertz, A., Elliott, C., Marino, S., Jochum, W., & Wagner, E. F. (2003) · Development · doi:10.1242/dev.00664 · Cited by 129 · see citing works

Internalization of functional epidermal growth factor:receptor/kinase complexes in A-431 cells.

Cohen, S., & Fava, R. A. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39032-4 · Cited by 127 · see citing works

PTEN-Mediated Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors

Mellinghoff, I. K., Cloughesy, T. F., & Mischel, P. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1992 · Cited by 126 · see citing works

Immunohistochemical analysis of the mutant epidermal growth factor, ΔEGFR, in glioblastoma

Nishikawa, R., Sugiyama, T., Narita, Y., et al. (2004) · Brain Tumor Pathology · doi:10.1007/bf02484510 · Cited by 123 · see citing works

Ectodomain shedding of the EGF‐receptor ligand epigen is mediated by ADAM17

Şahin, U., & Blobel, C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.074 · Cited by 122 · see citing works

Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity

Montemurro, F., Valabrega, G., & Aglietta, M. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.2.257 · Cited by 119 · see citing works

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck

Reuter, C. W., Morgan, M. A., & Eckardt, A. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603566 · Cited by 114 · see citing works

GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways

Hart, S., Fischer, O. M., Prenzel, N., et al. (2005) · Biological Chemistry · doi:10.1515/bc.2005.099 · Cited by 105 · see citing works

Growth Retardation, Duodenal Lesions, and Aberrant Ileum Architecture in Triple Null Mice Lacking EGF, Amphiregulin, and TGF-α

Troyer, K. L., Luetteke, N., Saxon, M. L., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.25478 · Cited by 103 · see citing works

Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity

Perera, R. M., Narita, Y., Furnari, F. B., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2653 · Cited by 103 · see citing works

Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas

Liu, L., Bäcklund, L. M., Nilsson, B. R., et al. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0700-2 · Cited by 103 · see citing works

Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478

Johns, T. G., Luwor, R. B., Murone, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036503100 · Cited by 100 · see citing works

Inhibition of ADAM17 reduces hypoxia‐induced brain tumor cell invasiveness

Zheng, X., Jiang, F., Katakowski, M., Kalkanis, S. N., Hong, X., Zhang, X., Zhang, Z. G., Yang, H., & Chopp, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00440.x · Cited by 95 · see citing works

Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients

Bei, R., Budillon, A., Masuelli, L., Cereda, V., Vitolo, D., Gennaro, E. D., Ripavecchia, V., Palumbo, C., Ionna, F., Losito, S., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1642 · Cited by 95 · see citing works

Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse.

Ruff-Jamison, S., McGlade, J. C., Pawson, T. J., Chen, K., & Cohen, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52996-3 · Cited by 92 · see citing works

The Role of the ErbB Family Members in Non–Small Cell Lung Cancers Sensitive to Epidermal Growth Factor Receptor Kinase Inhibitors

Engelman, J. A., & Cantley, L. C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0795 · Cited by 92 · see citing works

Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of North Central Cancer Treatment Group protocol N0177

Krishnan, S., Brown, P. D., Ballman, K. V., Fiveash, J. B., Uhm, J. H., Giannini, C., Jaeckle, K. A., Geoffroy, F. J., Nabors, B., & Buckner, J. C. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.018 · Cited by 90 · see citing works

Genetic Polymorphisms of the Epidermal Growth Factor and Related Receptor in Non-Small Cell Lung Cancer—A Review of the Literature

Araújo, A., Ribeiro, R. J. T., Azevedo, I., et al. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-201 · Cited by 89 · see citing works

Unligated Epidermal Growth Factor Receptor Forms Higher Order Oligomers within Microclusters on A431 Cells That Are Sensitive to Tyrosine Kinase Inhibitor Binding

Clayton, A. H. A., Tavarnesi, M. L., & Johns, T. G. (2007) · Biochemistry · doi:10.1021/bi700002b · Cited by 89 · see citing works

ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib

Frolov, A., Schuller, K., Tzeng, C.-W. D., Cannon, E. E., Ku, B. C., Howard, J. H., Vickers, S. M., Heslin, M. J., Buchsbaum, D. J., & Arnoletti, J. P. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.4.3849 · Cited by 89 · see citing works

Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy

Jimeno, A., Kulesza, P., Wheelhouse, J., Chan, A., Zhang, X., Kincaid, E., Chen, A. R., Clark, D. P., Forastiere, A. A., & Hidalgo, M. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603656 · Cited by 83 · see citing works

The Efficacy of Epidermal Growth Factor Receptor–Specific Antibodies against Glioma Xenografts Is Influenced by Receptor Levels, Activation Status, and Heterodimerization

Johns, T. G., Perera, R. M., Vernes, S. C., Vitali, A. A., Cao, D. X., Cavenee, W. K., Scott, A. M., & Furnari, F. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1453 · Cited by 81 · see citing works

Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line.

Sizeland, A. M., & Burgess, A. W. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.11.1235 · Cited by 77 · see citing works

Progesterone Receptor Repression of Prolactin/Signal Transducer and Activator of Transcription 5-Mediated Transcription of the β-Casein Gene in Mammary Epithelial Cells

Buser, A. C., Gass-Handel, E. K., Wyszomierski, S. L., Doppler, W., Leonhardt, S. A., Schaack, J. B., Rosen, J. M., Watkin, H., Anderson, S. M., & Edwards, D. P. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0297 · Cited by 76 · see citing works

Breast cancer: The upgraded role of HER-3 and HER-4

Karamouzis, M. V., Badra, F. A., & Papavassiliou, A. G. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.11.017 · Cited by 76 · see citing works

Distinct Domains in the SHP-2 Phosphatase Differentially Regulate Epidermal Growth Factor Receptor/NF-κB Activation through Gab1 in Glioblastoma Cells

Kapoor, G. S., Zhan, Y., Johnson, G. R., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.823-836.2004 · Cited by 74 · see citing works

Expression of ErbB receptors during pancreatic islet development and regrowth

Kritzik, M., Krahl, T., Good, A., et al. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650067 · Cited by 67 · see citing works

EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation

Kim, S., & Choi, K. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.02.003 · Cited by 63 · see citing works

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors

Spector, N. L., Xia, W., El‐Hariry, I. A., Yarden, Y., & Bacus, S. S. (2007) · Breast Cancer Research · doi:10.1186/bcr1652 · Cited by 62 · see citing works

PET imaging of acute and chronic inflammation in living mice

Cao, Q., Cai, W., Li, Z., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0451-0 · Cited by 62 · see citing works

ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti‐cancer therapy

Starr, A., Greif, J., Vexler, A. M., Ashkenazy‐Voghera, M., Gladesh, V., Rubin, C., Kerber, G., Marmor, S., Lev‐Ari, S., Inbar, M., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21818 · Cited by 59 · see citing works

Secretase-dependent Tyrosine Phosphorylation of Mdm2 by the ErbB-4 Intracellular Domain Fragment

Arasada, R. R., & Carpenter, G. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506057200 · Cited by 57 · see citing works

EGF receptor as a therapeutic target

Levitzki, A. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00134-x · Cited by 57 · see citing works

Combined Treatment of Bladder Cancer Cell Lines with Lapatinib and Varying Chemotherapy Regimens—Evidence of Schedule-Dependent Synergy

McHugh, L. A., Kriajevska, M. V., Mellon, J. K., et al. (2007) · Urology · doi:10.1016/j.urology.2006.12.003 · Cited by 56 · see citing works

Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant–dependent lung carcinomas

Li, D., Ji, H., Zaghlul, S., McNamara, K. L., Liang, M., Shimamura, T., Kubo, S., Takahashi, M., Chirieac, L. R., Padera, R. F., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30446 · Cited by 53 · see citing works

ERBB4/HER4 Potentiates STAT5A Transcriptional Activity by Regulating Novel STAT5A Serine Phosphorylation Events

Clark, D. E., Williams, C. C., Duplessis, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414044200 · Cited by 52 · see citing works

EGF receptor mutations in lung cancer: From humans to mice and maybe back to humans

Arteaga, C. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.014 · Cited by 50 · see citing works

Targeting ADAMS and ERBBs in lung cancer

Hynes, N. E., & Schlange, T. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.012 · Cited by 47 · see citing works

Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo

Feng, F. Y.-C., López, C., Normolle, D. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2582 · Cited by 47 · see citing works

Stimulated ErbB4 internalization is necessary for neuregulin signaling in neurons

Liu, Y., Tao, Y., Woo, R., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.009 · Cited by 46 · see citing works

Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation

Contessa, J. N., Abell, A., Mikkelsen, R. B., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9023-9 · Cited by 45 · see citing works

EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing

Ruhe, J. E., Streit, S., HART, S., & Ullrich, A. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.12.003 · Cited by 44 · see citing works

Protein kinase Cα mediates feedback inhibition of EGF receptor transactivation induced by Gq-coupled receptor agonists

Santiskulvong, C., & Rozengurt, E. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.01.006 · Cited by 42 · see citing works

An Oncogenic Epidermal Growth Factor Receptor Signals via a p21-activated Kinase-Caldesmon-Myosin Phosphotyrosine Complex

McManus, M. J., Boerner, J. L., Danielsen, A. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005399200 · Cited by 41 · see citing works

ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas.

Yasmeen, A., Bismar, T., & Moustafa, A.-E. A. (2006) · Future Oncology · doi:10.2217/14796694.2.6.765 · Cited by 41 · see citing works

Dissecting the Epidermal Growth Factor Receptor Signal Transactivation Pathway

Fischer, O. M., Hart, S., & Ullrich, A. (2006) · Humana Press eBooks · doi:10.1385/1-59745-012-x:85 · Cited by 39 · see citing works

What?s new in the renin-angiotensin system?

Smith, N. J., Chan, H., Osborne, J. E., et al. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4244-3 · Cited by 39 · see citing works

Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIα, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow

Schindlbeck, C., Hantschmann, P., Zerzer, M., et al. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.00920.x · Cited by 39 · see citing works

A Model for the Activation of the Epidermal Growth Factor Receptor Kinase: Involvement of an Asymmetric Dimer?

Groenen, L. C., Walker, F., Burgess, A. W., & Treutlein, H. R. (1997) · Biochemistry · doi:10.1021/bi9614141 · Cited by 35 · see citing works

Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?

Wierzbicka, E., Tourani, J. M., & Guillet, G. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07299.x · Cited by 34 · see citing works

The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors.

Sizeland, A. M., & Burgess, A. W. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.4005 · Cited by 34 · see citing works

Discovery of a Potent, Selective, and Orally Active Human Epidermal Growth Factor Receptor-2 Sheddase Inhibitor for the Treatment of Cancer

Yao, W., Zhuo, J., Burns, D., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061344o · Cited by 33 · see citing works

Phenotypic Variation Resulting From a Deficiency of Epidermal Growth Factor Receptor in Mice Is Caused by Extensive Genetic Heterogeneity That Can Be Genetically and Molecularly Partitioned

Strunk, K. E., Amann, V., & Threadgill, D. W. (2004) · Genetics · doi:10.1534/genetics.103.020495 · Cited by 32 · see citing works

Transforming Growth Factor Alpha (TGF-α) and Other Targets of Tumor Necrosis Factor-Alpha Converting Enzyme (TACE) in Murine Polycystic Kidney Disease

Nemo, R., Murcia, N. S., & Dell, K. M. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000159513.51898.60 · Cited by 30 · see citing works

Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy

Chen, Y., Liu, J. M., Chou, T., Perng, R.-P., Tsai, C., & Whang‐Peng, J. (2007) · Cancer · doi:10.1002/cncr.22616 · Cited by 29 · see citing works

Constitutive Activation of Neuregulin/ERBB3 Signaling Pathway in Clear Cell Sarcoma of Soft Tissue

Schaefer, K., Brachwitz, K., Braun, Y., et al. (2006) · Neoplasia · doi:10.1593/neo.06238 · Cited by 29 · see citing works

ErbB receptors in fetal endothelium—A potential linkage point for inflammation-associated neonatal disorders

Bueter, W., Dammann, O., Zscheppang, K., et al. (2006) · Cytokine · doi:10.1016/j.cyto.2007.02.002 · Cited by 28 · see citing works

Tackling the EGFR in pathological tissue remodelling

Chan, H., Smith, N. J., Hannan, R. D., & Thomas, W. G. (2005) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.04.005 · Cited by 28 · see citing works

Heregulin-dependent translocation and hyperphosphorylation of ErbB-2

Zhou, W., & Carpenter, G. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204517 · Cited by 27 · see citing works

The Future of ErbB-1 and ErbB-2 Pathway Inhibition in Breast Cancer: Targeting Multiple Receptors

Slamon, D. J. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_3-1 · Cited by 26 · see citing works

Response of Glioblastomas to EGFR Kinase Inhibitors

Lassman, A. B., Abrey, L. E., & Gilbert, M. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmc053459 · Cited by 26 · see citing works

Herceptin®: increasing survival in metastatic breast cancer

Slamon, D. (2000) · European Journal of Oncology Nursing · doi:10.1054/ejon.2000.0070 · Cited by 23 · see citing works

Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer

Masiello, D., Mohi, G., McKnight, N. C., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.2.3588 · Cited by 22 · see citing works

Cetuximab in the treatment of metastatic colorectal cancer

Moosmann, N., & Heinemann, V. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.2.243 · Cited by 21 · see citing works

Is There a Role for the Irreversible Epidermal Growth Factor Receptor Inhibitor EKB-569 in the Treatment of Cancer? A Mutation-Driven Question

Baselga, J. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3785 · Cited by 20 · see citing works

Effect of Dominant-Negative Epidermal Growth Factor Receptors on Cardiomyocyte Hypertrophy

Chan, H., Jenkins, A., Pipolo, L., et al. (2006) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890600923187 · Cited by 18 · see citing works

Identification of a novel EGF-sensitive cell cycle checkpoint

Walker, F., Zhang, H., & Burgess, A. W. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.026 · Cited by 17 · see citing works

Flat revertants derived from kirsten murine sarcoma virus‐transformed cells produce transforming growth factors

Salomon, D. S., Zwiebel, J. A., Noda, M., et al. (1984) · Journal of Cellular Physiology · doi:10.1002/jcp.1041210105 · Cited by 16 · see citing works

Are exon 19 deletions and L858R EGFR mutations in non-small-cell lung cancer clinically different?

Costa, D. B., & Kobayashi, S. S. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603564 · Cited by 12 · see citing works

Insights into the physiology of TGF alpha and signaling through the EGF receptor revealed by gene targeting and acts of nature.

Dunn, A., Mann, G. B., Kj, F., et al. (1994) · PubMed · Cited by 6 · see citing works

Epidermal growth factor receptor targeting in cancer: a review of trends and strategies

Yewale, C., Baradia, D., Vhora, I., Patil, S., & Misra, A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.100 · Cited by 533 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters

Mi, Y.-J., Liang, Y.-J., Huang, H.-B., Zhao, H.-Y., Wu, C.-P., Wang, F., Tao, L.-Y., Zhang, C.-Z., Dai, C.-L., Tiwari, A. K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0111 · Cited by 337 · see citing works

The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein

Lucas, L. M., Dwivedi, V., Senfeld, J. I., Cullum, R. L., Mill, C. P., Piazza, J. T., Bryant, I. N., Cook, L. J., Miller, S. T., Lott, J. H., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000381 · Cited by 70 · see citing works

Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases

Carraway, K. L., Weber, J. L., Unger, M. J., Ledesma, J., Yu, N., Gassmann, M., & Lai, C. (1997) · Nature · doi:10.1038/387512a0 · Cited by 394 · see citing works

The Role of the ErbB Family Members in Non–Small Cell Lung Cancers Sensitive to Epidermal Growth Factor Receptor Kinase Inhibitors

Engelman, J. A., & Cantley, L. C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0795 · Cited by 92 · see citing works

847 HDR vs. IDR brachytherapy for bladder cancer: disappointing local control and unexpected late toxicity

Pos, F. J., Horenblas, S., Schneider, C., et al. (2003) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(03)90873-1

Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.

Penington, D. J., Bryant, I., & Riese, D. J. (2002) · PubMed · Cited by 32 · see citing works

System-Wide Investigation of ErbB4 Reveals 19 Sites of Tyr Phosphorylation that Are Unusually Selective in their Recruitment Properties

Kaushansky, A., Gordus, A., Budnik, B., Lane, W. A. S., Rush, J., & MacBeath, G. (2008) · Chemistry and Biology · doi:10.1016/j.chembiol.2008.07.006 · Cited by 76 · see citing works